Metraipolis › archive › dc_c2e8ac8a5bcf

The prognostic value of peripheral blood inflammatory markers in patients with HER2-positive metastatic breast cancer treated with pyrotinib — Europe PMC PMID:42180115

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42180115
DOI
10.3389/fonc.2026.1812069
License (as archived)
solo-consultazione
Archived
2026-11-02T13:57:56.946Z
SHA-256 of the archived text
35dcac3e3ee0fc4029b7680fc8b300249efb054ed4f6f877377f88c2f7e7d4fc
Stable URL of this page
https://metraipolis.com/documento/dc_c2e8ac8a5bcf

How to cite

The prognostic value of peripheral blood inflammatory markers in patients with HER2-positive metastatic breast cancer treated with pyrotinib — Europe PMC PMID:42180115 — Europe PMC (en), https://europepmc.org/article/MED/42180115 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2e8ac8a5bcf (Metraipolis archive dc_c2e8ac8a5bcf, sha256 35dcac3e3ee0fc4029b7680fc8b300249efb054ed4f6f877377f88c2f7e7d4fc)
BibTeX
@misc{dcc2e8ac8a5bcf,
  title = {The prognostic value of peripheral blood inflammatory markers in patients with HER2-positive metastatic breast cancer treated with pyrotinib — Europe PMC PMID:42180115},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180115},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2e8ac8a5bcf; sha256 35dcac3e3ee0fc4029b7680fc8b300249efb054ed4f6f877377f88c2f7e7d4fc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180115. Agents can read the archived copy with the MCP tool read_document.